{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:10:56Z","timestamp":1768741856589,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The effectiveness of a new antibody treatment on arthritis-associated osteolysis was studied by using CIA mice. GGT, a newly identified bone-resorbing factor, was upregulated in arthritic joints. We generated monoclonal antibodies against GGT and injected them into CIA mice. Mice treated with antibodies showed a reduction in osteoclast number and bone erosion.<\/jats:p>\n               <jats:p>Introduction: \u03b3-Glutamyl transpeptidase (GGT) acts as a bone-resorbing factor that stimulates osteoclast formation. GGT expression has been detected in active lymphocytes that accumulate at inflammation sites, such as rheumatoid arthritis (RA). We hypothesize that GGT is an effective target for suppression of arthritis-related osteoclastogenesis and joint destruction. Here, we describe the therapeutic effect of neutralizing antibodies against GGT on joint destruction using a collagen-induced arthritis (CIA) mouse model.<\/jats:p>\n               <jats:p>Materials and Methods: GGT expression in the synovium of RA patients and CIA mice was determined by immunohistochemistry and RT-PCR. Monoclonal antibodies were generated against recombinant human GGT (GGT-mAbs) using BALB\/c mice. Antibody treatment was performed by intraperitoneal injections of GGT-mAbs into CIA mice. Effects of antibody treatment on arthritis and bone erosion were evaluated by incidence score, arthritis score, and histopathological observations. The role of GGT in osteoclast development was examined by using the established osteoclastogenic culture system.<\/jats:p>\n               <jats:p>Results: GGT expression was significantly upregulated in inflamed synovium. Immunohistochemistry revealed that GGT was present in lymphocytes, plasma cells, and macrophages, as well as capillaries. Injection of GGT-mAbs significantly decreased the number of osteoclasts and attenuated the severity of joint destruction in CIA mice. In vitro examination showed that GGT enhanced RANKL-dependent osteoclast formation. GGT stimulated the expression of RANKL in osteoblasts and its receptor RANK in osteoclast precursors, respectively.<\/jats:p>\n               <jats:p>Conclusions: This study indicates that inflamed synovial tissue\u2013derived GGT acts as a risk factor for joint destruction and that the antibody-mediated inhibition of GGT significantly decreases osteoclast number and bone erosion in CIA mice. GGT antagonists might be novel therapeutic agents for attenuating joint destruction in RA patients.<\/jats:p>","DOI":"10.1359\/jbmr.070726","type":"journal-article","created":{"date-parts":[[2007,8,6]],"date-time":"2007-08-06T19:31:07Z","timestamp":1186428667000},"page":"1933-1942","source":"Crossref","is-referenced-by-count":21,"title":["Treatment With Anti-\u03b3-Glutamyl Transpeptidase Antibody Attenuates Osteolysis in Collagen-Induced Arthritis Mice"],"prefix":"10.1093","volume":"22","author":[{"given":"Yasuyuki","family":"Ishizuka","sequence":"first","affiliation":[{"name":"Department of Bone and Joint Disease, The Research Institute, National Center for Geriatrics and Gerontology (NCGG), Obu, Aichi, Japan"},{"name":"Applied Cell Biotechnologies, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Moriwaki","sequence":"additional","affiliation":[{"name":"Department of Bone and Joint Disease, The Research Institute, National Center for Geriatrics and Gerontology (NCGG), Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Kawahara-Hanaoka","sequence":"additional","affiliation":[{"name":"Ishida Dental and Orthodontics Clinic, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Uemura","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Laboratories, Kirin Brewery Co., Takasaki, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Serizawa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Laboratories, Kirin Brewery Co., Takasaki, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical Sciences Hiroshima University, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Osaka University Medical School, Osaka, Japan"},{"name":"Department of Biochemistry, Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimichi","family":"Kanaya","sequence":"additional","affiliation":[{"name":"Ina Bio-Center, Kitayama Labes Co., Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical Sciences Hiroshima University, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Osaka University Medical School, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumpei","family":"Niida","sequence":"additional","affiliation":[{"name":"Department of Bone and Joint Disease, The Research Institute, National Center for Geriatrics and Gerontology (NCGG), Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020319241824900_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11926-002-0069-y","article-title":"Pathogenesis of bone lesions in rheumatoid arthritis","volume":"2","author":"Goldring","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"2024020319241824900_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"2024020319241824900_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","article-title":"RANK-L and RANK: T cells, bone loss, and mammalian evolution","volume":"20","author":"Theill","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"2024020319241824900_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: Involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"2024020319241824900_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/bbrc.1997.7404","article-title":"A new mechanism of bone destruction in rheumatoid arthritis: Synovial fibroblasts induce osteoclastogenesis","volume":"240","author":"Takayanagi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"2024020319241824900_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0765.2005.00814.x","article-title":"Inflammatory bone destruction and osteoimmunology","volume":"40","author":"Takayanagi","year":"2005","journal-title":"J Periodont Res"},{"key":"2024020319241824900_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/ar431","article-title":"The molecular mechanism of osteoclastogenesis in rheumatoid arthritis","volume":"4","author":"Udagawa","year":"2002","journal-title":"Arthritis Res"},{"key":"2024020319241824900_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0167-4889(99)00039-7","article-title":"Induction of hydroxyapatite resorptive activity in bone marrow cell populations resistant to bafilomycin A1 by a factor with restricted expression to bone and brain, neurochondrin","volume":"1450","author":"Ishizuka","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"2024020319241824900_bib9","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1074\/jbc.M311905200","article-title":"Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor","volume":"279","author":"Niida","year":"2004","journal-title":"J Biol Chem"},{"key":"2024020319241824900_bib10","first-page":"1175","article-title":"gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?","volume":"147","author":"Lieberman","year":"1995","journal-title":"Am J Pathol"},{"key":"2024020319241824900_bib11","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/en.2007-0215","article-title":"Overexpression of \u03b3-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis","volume":"148","author":"Hiramatsu","year":"2007","journal-title":"Endocrinology"},{"key":"2024020319241824900_bib12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/44.10.8813074","article-title":"Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue","volume":"44","author":"Hanigan","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"2024020319241824900_bib13","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1073\/pnas.73.7.2414","article-title":"gamma-Glutamyl transpeptidase, a lymphoid cell-surface marker: Relationship to blastogenesis, differentiation, and neoplasia","volume":"73","author":"Novogrodsky","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319241824900_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/bchm3.1993.374.1-6.287","article-title":"The activity of gamma-glutamyl transpeptidase (gamma-GT) in populations of mononuclear cells from human peripheral blood","volume":"374","author":"Grisk","year":"1993","journal-title":"Biol Chem Hoppe Seyler"},{"key":"2024020319241824900_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/intimm\/dxg010","article-title":"Gamma-glutamyl transpeptidase activity alters the T cell response to oxidative stress and Fas-induced apoptosis","volume":"15","author":"Carlisle","year":"2003","journal-title":"Int Immunol"},{"key":"2024020319241824900_bib16","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/1521-4141(200007)30:7<1902::AID-IMMU1902>3.0.CO;2-A","article-title":"Gamma-glutamyltranspeptidase knockout mice as a model for understanding the consequences of diminished glutathione on T cell-dependent immune responses","volume":"30","author":"Lawrence","year":"2000","journal-title":"Eur J Immunol"},{"key":"2024020319241824900_bib17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/intimm\/11.11.1791","article-title":"Gamma-glutamyl transpeptidase is up-regulated on memory T lymphocytes","volume":"11","author":"Karp","year":"1999","journal-title":"Int Immunol"},{"key":"2024020319241824900_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.1780290314","article-title":"Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies","volume":"29","author":"Holmdahl","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2024020319241824900_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1073\/pnas.92.1.126","article-title":"Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain","volume":"92","author":"Ikeda","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319241824900_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004180100298","article-title":"Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide","volume":"116","author":"Miyauchi","year":"2001","journal-title":"Histochem Cell Biol"},{"key":"2024020319241824900_bib21","first-page":"1154","article-title":"Osteoclast-like cells in murine collagen induced arthritis","volume":"25","author":"Suzuki","year":"1998","journal-title":"J Rheumatol"},{"key":"2024020319241824900_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/rheumatology\/40.6.673","article-title":"Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium","volume":"40","author":"Suzuki","year":"2001","journal-title":"Rheumatology"},{"key":"2024020319241824900_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1359\/JBMR.051025","article-title":"Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II","volume":"21","author":"Katagiri","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319241824900_bib24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.185.6.1005","article-title":"Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte\/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation","volume":"185","author":"Udagawa","year":"1997","journal-title":"J Exp Med"},{"key":"2024020319241824900_bib25","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.4049\/jimmunol.177.7.4360","article-title":"Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine\/receptor activation of NF-kB ligand","volume":"177","author":"Mochizuki","year":"2006","journal-title":"J Immunol"},{"key":"2024020319241824900_bib26","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/IAI.71.6.3572-3577.2003","article-title":"Helicobacter-induced chronic activity lymphoid aggregates have characteristics of tertiary lymphoid tissue","volume":"71","author":"Shomer","year":"2003","journal-title":"Infect Immunol"},{"key":"2024020319241824900_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"2024020319241824900_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/oxfordjournals.bmb.a072970","article-title":"Hypoxia, oxidative stress and rheumatoid arthritis","volume":"51","author":"Mapp","year":"1995","journal-title":"Br Med Bull"},{"key":"2024020319241824900_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0167-5699(99)01552-2","article-title":"Rheumatoid arthritis and p53: How oxidative stress might alter the course of inflammatory diseases","volume":"21","author":"Tak","year":"2000","journal-title":"Immunol Today"},{"key":"2024020319241824900_bib30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm939","article-title":"TNF define as a therapeutic target for rheumatoid arthritis and other autoimmune diseases","volume":"9","author":"Feldmann","year":"2003","journal-title":"Nat Med"},{"key":"2024020319241824900_bib31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"2024020319241824900_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14740338.5.1.9","article-title":"Toxicity of infliximab in the course of treatment of Crohn's disease","volume":"5","author":"Bratcher","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"2024020319241824900_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2006.06.098","article-title":"Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody","volume":"347","author":"Kamijo","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2024020319241824900_bib34","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/art.21826","article-title":"Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study","volume":"54","author":"Straub","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.070726","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/12\/1933\/56551101\/5650221214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/12\/1933\/56551101\/5650221214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:49:39Z","timestamp":1710341379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/22\/12\/1933-1942\/7597191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.070726","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,12,1]]},"published":{"date-parts":[[2007,12,1]]}}}